AU4955593A - Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum - Google Patents

Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum

Info

Publication number
AU4955593A
AU4955593A AU49555/93A AU4955593A AU4955593A AU 4955593 A AU4955593 A AU 4955593A AU 49555/93 A AU49555/93 A AU 49555/93A AU 4955593 A AU4955593 A AU 4955593A AU 4955593 A AU4955593 A AU 4955593A
Authority
AU
Australia
Prior art keywords
hepatitis
reactivity
surface antigen
showing cross
peptide showing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49555/93A
Inventor
Venkatasamy Manivel
Subrat Kumar Panda
Kanury Venkattasubba Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNITED NATIONS INDUSTRIAL DEVELOPMENT ORGANIZATION
Original Assignee
UNITED NATIONS IND DEV ORGANIZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNITED NATIONS IND DEV ORGANIZ filed Critical UNITED NATIONS IND DEV ORGANIZ
Publication of AU4955593A publication Critical patent/AU4955593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU49555/93A 1992-09-01 1993-08-30 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum Abandoned AU4955593A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT174692 1992-09-01
AT1746/92 1992-09-01
PCT/EP1993/002342 WO1994005698A1 (en) 1992-09-01 1993-08-30 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum

Publications (1)

Publication Number Publication Date
AU4955593A true AU4955593A (en) 1994-03-29

Family

ID=3520114

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49555/93A Abandoned AU4955593A (en) 1992-09-01 1993-08-30 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum

Country Status (3)

Country Link
EP (1) EP0662085A1 (en)
AU (1) AU4955593A (en)
WO (1) WO1994005698A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948533A1 (en) * 1996-12-30 1999-10-13 Innogenetics N.V. ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses

Also Published As

Publication number Publication date
EP0662085A1 (en) 1995-07-12
WO1994005698A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
EP0627932A4 (en) Novel antibody construct.
AU7411896A (en) Bispecific antibody heterodimers
HU9601574D0 (en) Humanized antibodies and uses thereof
DK145493D0 (en) ANTIBODY
AU4618193A (en) Humanized antibodies
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU3459593A (en) Humanised antibody against hepatitis
GB9412166D0 (en) Retargetting antibodies
EP0580859A4 (en) Anti-eda monoclonal antibody
IL100841A0 (en) Immunoassay
AU3330689A (en) Monoclonal antibodies
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
EP0506523A3 (en) Monoclonal antibodies
AU4955593A (en) Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum
GB2309522B (en) An immunoassay for fungal antigens
AU4195793A (en) Bispecific antibody
EP0586026A3 (en) Characterization of a novel anti-p110RB monoclonal antibody.
EP0553077A4 (en) Monoclonal antibodies to cyclodiene insecticides and method for detecting the same
AU8003894A (en) Antigen peptide compound and immunoassay method
EP0654532A4 (en) Antimucoglycoprotein monoclonal antibody.
GB9115010D0 (en) Antibody
EP0668923A4 (en) Monoclonal antibody.
GB9212074D0 (en) Monoclonal antibody
GB9324471D0 (en) Antibody blocking peptides
GB9226163D0 (en) Antibody blocking peptides